153 related articles for article (PubMed ID: 3084071)
1. Characterization of lymphocytic infiltrates in normal, preneoplastic, and neoplastic mouse mammary tissues.
Wei WZ; Malone K; Mahoney K; Heppner G
Cancer Res; 1986 Jun; 46(6):2680-5. PubMed ID: 3084071
[TBL] [Abstract][Full Text] [Related]
2. Elimination of V beta 2 bearing T-cells in BALB/c mice implanted with syngeneic preneoplastic and neoplastic mammary lesions.
Wei WZ; Ficsor-Jacobs R; Tsai SJ; Pauley R
Cancer Res; 1991 Jun; 51(12):3331-3. PubMed ID: 2040009
[TBL] [Abstract][Full Text] [Related]
3. Associated effects of bromocriptine on neoplastic progression of mouse mammary preneoplastic hyperplastic alveolar nodule line C4 and on hyperplastic alveolar nodule-infiltrating and splenic lymphocyte function.
Tsai SJ; Loeffler DA; Heppner GH
Cancer Res; 1992 Apr; 52(8):2209-15. PubMed ID: 1559224
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of keratin expression in mouse mammary hyperplastic alveolar nodules and adenocarcinomas.
Asch HL; Asch BB
Cancer Res; 1985 Jun; 45(6):2760-8. PubMed ID: 2580627
[TBL] [Abstract][Full Text] [Related]
5. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.
Medina D; Kittrell FS; Oborn CJ; Schwartz M
Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201
[TBL] [Abstract][Full Text] [Related]
6. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
[TBL] [Abstract][Full Text] [Related]
7. Correlation of natural killer activity with tumorigenesis of a preneoplastic mouse mammary lesion.
Wei WZ; Fulton A; Winkelhake J; Heppner G
Cancer Res; 1989 May; 49(10):2709-15. PubMed ID: 2785436
[TBL] [Abstract][Full Text] [Related]
8. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
Buessow SC; Paul RD; Lopez DM
J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
[TBL] [Abstract][Full Text] [Related]
9. Concanavalin A-induced agglutinability of normal, preneoplastic, and neoplastic mouse mammary cells.
Asch BB; Medina D
J Natl Cancer Inst; 1978 Dec; 61(6):1423-30. PubMed ID: 281551
[TBL] [Abstract][Full Text] [Related]
10. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of mouse hyperplastic mammary outgrowth lines from BALB/cfC3H hyperplastic alveolar nodules.
Ashley RL; Cardiff RD; Mitchell DJ; Faulkin LJ; Lund JK
Cancer Res; 1980 Nov; 40(11):4232-42. PubMed ID: 6258774
[TBL] [Abstract][Full Text] [Related]
12. Expression of pregnancy-specific genes in preneoplastic mouse mammary tissues from virgin mice.
Smith GH; Vonderhaar BK; Graham DE; Medina D
Cancer Res; 1984 Aug; 44(8):3426-37. PubMed ID: 6430550
[TBL] [Abstract][Full Text] [Related]
13. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
[TBL] [Abstract][Full Text] [Related]
14. X-ray microanalysis of electrolyte content of normal, preneoplastic, and neoplastic mouse mammary tissue.
Smith NK; Stabler SB; Cameron IL; Medina D
Cancer Res; 1981 Oct; 41(10):3877-80. PubMed ID: 7284996
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic capacity of preneoplastic lesions of the murine mammary gland as a marker of neoplastic transformation.
Gimbrone MA; Gullino PM
Cancer Res; 1976 Jul; 36(7 PT 2):2611-20. PubMed ID: 1277168
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies directed against preneoplastic and neoplastic murine mammary lesions.
Johnson CW; Wei WZ; Barth RF; Tuttle SE; Andrews CA
Cancer Res; 1985 Aug; 45(8):3774-81. PubMed ID: 3893690
[TBL] [Abstract][Full Text] [Related]
17. Preneoplastic lesions in murine mammary cancer.
Medina D
Cancer Res; 1976 Jul; 36(7 PT 2):2589-95. PubMed ID: 179706
[TBL] [Abstract][Full Text] [Related]
18. Changes in the host lymphocyte subsets during chemical carcinogenesis.
Brodt P; Lala PK
Cancer Res; 1983 Sep; 43(9):4315-22. PubMed ID: 6871866
[TBL] [Abstract][Full Text] [Related]
19. Effect of megestrol acetate or melengestrol acetate on preneoplastic and neoplastic mammary growth in mice.
Nagasawa H; Sakagami N; Ohbayashi R; Yamamoto K; Petrow V
Anticancer Res; 1988; 8(6):1399-403. PubMed ID: 3218973
[TBL] [Abstract][Full Text] [Related]
20. Microcytotoxicity assay of immune responses to non-mammary tumor virus-induced, preneoplastic, and neoplastic mammary lesions in BALB/c mice.
Heppner GH; Kopp JS; Medina D
Cancer Res; 1976 Feb; 36(2 pt 2):753-8. PubMed ID: 1253160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
